Advertisement

Reactions Weekly

, Volume 1747, Issue 1, pp 209–209 | Cite as

Nivolumab

Renal allograft rejection and renal failure: case report
Case report
  • 34 Downloads

Reference

  1. Aguirre LE, et al. Immune Checkpoint Inhibitors and the Risk of Allograft Rejection: A Comprehensive Analysis on an Emerging Issue. Oncologist 24: 394-401, No. 3, Mar 2019. Available from: URL: http://doi.org/10.1634/theoncologist.2018-0195 - USACrossRefGoogle Scholar

Copyright information

© Springer International Publishing AG 2019

Personalised recommendations